Impact of beta-blockers on long-term mortality in Takotsubo syndrome: a real-world analysis of the TriNetX Global Collaborative Network database

Does beta-blocker use reduce short- and long-term mortality in patients with Takotsubo syndrome?

Real-world data suggests beta-blocker use is associated with improved short- and long-term survival up to 5 years in patients with Takotsubo syndrome.